Ceftazidime Injection USP 1gm represents a sterile antibiotic formulation containing Ceftazidime Pentahydrate equivalent to 1000mg Ceftazidime, combined with Sodium Carbonate for o...

Ceftazidime Injection USP 1gm represents a sterile antibiotic formulation containing Ceftazidime Pentahydrate equivalent to 1000mg Ceftazidime, combined with Sodium Carbonate for optimal stability and solubility. As a third-generation cephalosporin, it demonstrates exceptional broad-spectrum activity against challenging Gram-negative pathogens including Pseudomonas aeruginosa strains. Manufactured under rigorous aseptic conditions that comply with United States Pharmacopeia standards, this injection guarantees purity, consistent potency, and patient safety. Designed for either intravenous or intramuscular administration, it delivers rapid therapeutic action precisely when prompt antibiotic intervention becomes critical for patient outcomes. The product packaging maintains sterility throughout storage and handling while facilitating straightforward administration for healthcare professionals.

This injection serves as fundamental treatment across hospital intensive care units, surgical centers, emergency departments, and specialized clinics managing serious infections. Medical professionals utilize it extensively in oncology departments for neutropenic patients, burn units for sepsis prevention, and critical care for ventilator-associated pneumonia cases. Pharmaceutical distributors supply this product to government healthcare programs, private hospital networks, and emergency medical services, ensuring continuous availability for life-saving interventions. Its proven reliability establishes it as a cornerstone in infectious disease management protocols within modern healthcare systems worldwide, supporting consistent patient care standards.

For importers, distributors, and healthcare suppliers, this product delivers substantial business value through its unwavering quality, regulatory compliance, and sustained market demand. Its reliability minimizes risks associated with product efficacy concerns or supply chain disruptions, building enduring trust with medical facilities and practitioners. The product's consistent performance and therapeutic effectiveness create repeated procurement cycles and long-term partnership opportunities within competitive pharmaceutical distribution networks. By incorporating this critical-care injection into their portfolio, businesses secure a proven product with steady demand that strengthens their market position and supports reliable revenue streams.

Key Features:
- Contains Ceftazidime Pentahydrate equivalent to 1000mg Ceftazidime per vial
- Sterile formulation with Sodium Carbonate ensuring stability and solubility
- Manufactured under strict aseptic conditions meeting USP standards
- Effective against Gram-negative bacteria including Pseudomonas aeruginosa
- Suitable for both intravenous and intramuscular administration methods

Benefits:
- Delivers reliable broad-spectrum coverage for severe bacterial infections
- Ensures patient safety through sterile manufacturing and quality control
- Provides flexible administration options for different clinical scenarios
- Supports healthcare professionals with consistent therapeutic performance
- Meets stringent regulatory standards for pharmaceutical distribution